Differential expression of nonislet autoimmunity: Comparison of Korean and U.S. patients with type 1 diabetes

Annals of the New York Academy of Sciences

Volumn 1037, Issue , 2004, Pages 69-73

  Park, Yongsoo ^a,c   Kim, Sinkyu ^a   Park, Sukyung ^a   Kim, Taewha ^a   Yu, Liping ^b   Rewers, Marian ^b   Eisenbarth, George S ^b  

^a Hanyang University   (South Korea)

^b UNIVERSITY OF COLORADO DENVER   (United States)

^c Hanyang University College of Medicine   (South Korea)

Author keywords

21 Hydroxylase; Antithyroid antibodies; Polyendocrinopathy; Transglutaminase; Type 1 diabetes

Indexed keywords

C PEPTIDE; GENOMIC DNA; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; STEROID 21 MONOOXYGENASE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ASIAN; AUTOIMMUNITY; CAUCASIAN; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE DURATION; FAMILY HISTORY; FEMALE; HAPLOTYPE; HUMAN; IMMUNOGENETICS; INSULIN DEPENDENT DIABETES MELLITUS; KOREA; MAJOR CLINICAL STUDY; MALE; RADIOIMMUNOASSAY; SEROPREVALENCE; STATISTICAL ANALYSIS; UNITED STATES;

EID: 14544305159     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1337.010     Document Type: Conference Paper

References (6)

1. PARK, Y. et al. 2001. Evaluation of the efficacy of the combination of multiple autoantibodies to islet-specific antigens in Korean type 1 diabetic patients. Acta Diabetol. 38: 51-56.
2. OKAI, K. et al. 1983. Comparative studies on immunological characteristics of IDDM among Asian populations. Tohoku J. Exp. Med. 141(Suppl.): 289-293.
3. KO, K. et al. 1994. The incidence of IDDM in Seoul from 1985 to 1988. Diabetes Care 17: 1473-1475.
4. YU, L. et al. 1999. DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J. Clin. Endocrinol. Metab. 84: 328-335.
5. BAO, F. et al. 1999. One-third of HLA DQ2 humozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies. J. Autoimmun. 13: 143-148.
6. LIU, E. et al. 2002. Type 1A diabetes-associated autoimmunity. Endocrinol. Metab. Clin. N. Am. 31:391-410.